-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Thomas Kaulhausen
Methodology: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for breast cancer research: the BIG experience
Michael Gnant, Martine Piccart-Gebhart, Aron Goldhirsch, Jose Baselga, David Cameron, Angelo Di Leo, Mitchell Dowsett, Richard Gelber, Gunter von Minckwitz, Cecilia Waldvogel, Carolyn Straehle
Clinical Trail Outcomes: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation